Aging Cell April 2016 PMID 26663466

Methylene blue alleviates nuclear and mitochondrial abnormalities in progeria.

Zheng-Mei Xiong, Ji Young Choi, Kun Wang, Haoyue Zhang, Zeshan Tariq, Di Wu, Eunae Ko, Christina LaDana, Hiromi Sesaki, Kan Cao

Mentions

33
Peak: 1 in Apr 2021
across 6 sources since Apr 2021

Extended reach

4,983
potential audience

Total likes

65

Video views

929

Mentions per month

Apr 2021 – Apr 2025

Where it's discussed

  • News20 articles
  • Facebook5 posts
  • X / Twitter3 posts
  • Reddit2 posts
  • Blogs2 articles
  • YouTube1 videos

AI synopsis

What people are saying

The analysis reflects a cautious yet intrigued sentiment, with comments emphasizing the significance of mitochondrial health and genetic factors, such as mentions of PGC-1α and nuclear abnormalities, using technical language that demonstrates in-depth engagement. Words like 'impressive' and references to 'favorable findings' reveal moderate interest, while skepticism about commercial motives suggests nuanced agreement overall.

AgreementNeither agree nor disagree

The discussions display mixed opinions, with some acknowledging the findings as impressive but also suggesting skepticism about commercial interests.

InterestModerate interest

Most posts express curiosity or recognition of the scientific significance, showing a moderate but genuine interest.

EngagementHigh engagement

Posts delve into detailed discussions of mitochondrial function, gene expression, and the potential implications of methylene blue, indicating deep engagement.

ImpactModerate impact

The conversations highlight the potential importance of these findings for aging-related diseases, but some skepticism about practical impact limits the perceived high impact.

Abstract in brief

  • Mitochondrial abnormalities such as swelling, fragmentation, and reduced mobility are prominent in HGPS cells, and the expression of a key regulator, PGC1, is inhibited, contributing to the disease.
  • Treatment with the antioxidant methylene blue (MB) was shown to improve mitochondrial function and also fix nuclear abnormalities and gene expression issues in HGPS cells.
  • These findings highlight the importance of mitochondrial health in aging-related diseases like HGPS and suggest that MB could be a potential therapy to combat premature aging symptoms.]

Top posts

Most liked on X and Bluesky
tune
@keisuke4713 · X

MBで早老症の核/ミトコンドリア異常⬇️ https://t.co/R7EhLyYFAf 致命的早期老化Hutchinson–Gilford progeria症候群(HGPS) LMNA一塩基遺伝子変異で起きる 膨潤・断片化mitochondria⬆️⬆️HGPS線維芽細胞のmitochondria移動度⬇️⬇️ mitochondria生合成の中心調節因子PGC-1α発現はプロジェリンで阻害された

May 9, 2022 · 1 like · 3,743 followers View post →
amor_fati
@MotoSpecialcom · X

@mitokondriac https://t.co/rTQJdIdnav - https://t.co/BAgxyytoiT - https://t.co/ERUAwUbgXA - https://t.co/AEcxbEZIAW - https://t.co/FeJsNp3XqS - https://t.co/PwUm2gRmO4 - https://t.co/xIW8yrjrWA - https://t.co/vN88u4Nl1B - https://t.co/XZsKB7Omyq varios enlaces separados por -

Apr 17, 2021 · 1 like · 38 followers View post →

All mentions

Negative Tw!tter User v2.0
@geranamine · X

@GOV_OTP_BTP_FTP @MaileOnX @VanceE I think it's the opposite... there's no money to be made with MB so of course no real interest, however there's some real incredibly favorable findings IMO. Since you bring up 'anti-aging', this is impressive: https://t.co/YNdEohwWlp

Feb 5, 2025 · 274 followers View post →
tune
@keisuke4713 · X

MBで早老症の核/ミトコンドリア異常⬇️ https://t.co/R7EhLyYFAf 致命的早期老化Hutchinson–Gilford progeria症候群(HGPS) LMNA一塩基遺伝子変異で起きる 膨潤・断片化mitochondria⬆️⬆️HGPS線維芽細胞のmitochondria移動度⬇️⬇️ mitochondria生合成の中心調節因子PGC-1α発現はプロジェリンで阻害された

May 9, 2022 · 1 like · 3,743 followers View post →
amor_fati
@MotoSpecialcom · X

@mitokondriac https://t.co/rTQJdIdnav - https://t.co/BAgxyytoiT - https://t.co/ERUAwUbgXA - https://t.co/AEcxbEZIAW - https://t.co/FeJsNp3XqS - https://t.co/PwUm2gRmO4 - https://t.co/xIW8yrjrWA - https://t.co/vN88u4Nl1B - https://t.co/XZsKB7Omyq varios enlaces separados por -

Apr 17, 2021 · 1 like · 38 followers View post →